Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

TVTX Stock Annual Balance Sheet. Download in Excel

Travere Therapeutics Inc. logo

Travere Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

18.26
 
USD
  
0.40
  
(2.24%)
Previous close: 17.86  Open: 17.96  Bid: 17.75  Ask: 18.66
52 week range    
5.12   
   20.33
Mkt Cap: 1,357 M  Avg Vol (90 Days): 1,920,224
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Friday 22nd November 2024

Stock Rankings

50
MarketXLS Rank
40
Value
61
Technical
50
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

TVTX Balance Sheet

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Accounts payable7 M8 M8 M19 M7 M27 M12 M15 M17 M42 M
Accounts receivable8 M12 M19 M14 M13 M18 M16 M16 M17 M21 M
Accrued expenses36 M33 M43 M57 M57 M78 M69 M90 M113 M161 M
AccruedInterestReceivable900000.02 M5 M
Accumulated depreciation & depletion0.0-5 M-200000.0-1 M-1 M-2 M-4 M-3 M-5 M-7 M
Additional paid in capital141 M366 M421 M472 M590 M637 M798 M1,069 M1,060 M1,328 M
Cash and equivalents18 M38 M41 M99 M103 M62 M85 M166 M62 M58 M
CashCashEquivalentsAndShortTermInvestments28 M230 M256 M301 M472 M399 M362 M553 M450 M567 M
CashEquivalents41 M103 M62 M
Common par3000.04000.04000.04000.04000.04000.05000.06000.06000.07000.0
Common stock equity-37 M300 M308 M293 M318 M221 M211 M302 M43 M201 M
CommonStock3000.04000.04000.04000.04000.04000.05000.06000.06000.07000.0
Cost in excess936000.0936000.0936000.0936000.0936000.0936000.0900000.0900000.0800000.0800000.0
CurrentAccruedExpenses29 M26 M35 M38 M50 M52 M57 M75 M96 M119 M
CurrentCapitalLeaseObligation0.00.03 M357000.04 M4 M5 M
CurrentDeferredRevenue16 M12 M7 M
CurrentDeferredTaxesAssets0.0
CurrentDeferredTaxesLiabilities8 M54 M34 M17 M14 M3 M-20 M-17 M-7 M-6 M
CurrentProvisions10 M45 M71 M81 M74 M
Deferred revenues16 M12 M7 M
DeferredFinancingCosts-9 M-9 M
Finished goods486000.02 M1 M2 M3 M3 M4 M2 M2 M2 M
Float term debt9 M244 M258 M403 M400 M
GoodwillAndOtherIntangibleAssets95 M162 M183 M186 M188 M158 M154 M148 M97 M104 M
Gross fixed assets (Plant Property & Equipment)671000.0428000.03 M5 M4 M5 M39 M37 M35 M33 M
Intangibles94 M162 M182 M185 M187 M157 M154 M148 M97 M104 M
InterestPayable7 M8 M800000.04 M10 M19 M19 M20 M11 M11 M
Inventories801000.03 M3 M5 M6 M6 M8 M7 M5 M9 M
InventoriesAdjustmentsAllowances-100000.0-300000.0-600000.0-700000.0-2 M-3 M-4 M-4 M-1 M-3 M
Invested capital6 M344 M352 M338 M513 M435 M670 M787 M821 M978 M
LongTermCapitalLeaseObligation12 M28 M31 M28 M23 M
LongTermDebtAndCapitalLeaseObligation43 M44 M44 M45 M195 M205 M244 M258 M403 M400 M
LongTermProvisions11 M9 M8 M13 M74 M62 M48 M
Net fixed assets (net PP&E)671000.0428000.03 M3 M3 M3 M35 M34 M30 M26 M
NetOtherUnrealizedGainLoss103000.0900000.0550000.00.0
Non-current deferred income taxes141000.024 M6 M
NonCurrentDeferredLiabilities141000.024 M6 M20 M11 M2 M
NonCurrentDeferredRevenue20 M11 M2 M
NonCurrentDeferredTaxesAssets44 M37 M58 M44 M69 M104 M168 M215 M300 M296 M
NonCurrentNoteReceivables0.046 M0.0
Notes payable40 M
NotesReceivable0.047 M47 M
Other current assets24 M33 M2 M4 M235000.05 M8 M3 M23 M
Other equity adjustments-490000.0-1 M-2 M726000.0
Other fixed assets671000.0428000.07 M35 M34 M30 M26 M
Other non-current assets2 M2 M7 M6 M8 M15 M8 M11 M59 M42 M
Other non-current liabilities5 M17 M4 M12 M18 M29 M60 M72 M9 M8 M
Other receivable155 M164 M175 M198 M227 M109 M145 M
OtherCurrentLiabilities206000.0958000.018 M4 M26 M9 M23 M14 M13 M5 M
OtherInventories801000.03 M8 M7 M5 M9 M
OtherPayable29 M33 M10 M13 M19 M15 M95 M547 M28 M42 M
Payables7 M8 M8 M19 M7 M27 M12 M15 M17 M42 M
Preferred securities of subsidiary trust20 M20 M20 M20 M
PreferredStock20 M20 M20 M20 M
Prepaid expenses813000.010 M8 M6 M6 M5 M8 M7 M12 M19 M
Raw materials315000.0289000.01 M3 M3 M3 M3 M5 M2 M34 M
RecievablesAdjustmentsAllowances-100000.0-300000.0-200000.0
Restricted cash0.0
Retained earnings-175 M-66 M-113 M-178 M-270 M-416 M-587 M-767 M-1,017 M-1,127 M
Short term debt40 M22 M
TaxesReceivable1 M17 M247000.0
Total assets135 M512 M525 M520 M709 M605 M607 M777 M673 M789 M
Total current assets37 M302 M332 M326 M496 M429 M410 M583 M486 M617 M
Total current liabilities114 M118 M83 M86 M105 M95 M93 M124 M142 M178 M
Total equity-37 M300 M308 M293 M318 M221 M211 M302 M43 M201 M
Total liabilities173 M212 M218 M227 M391 M384 M396 M475 M630 M588 M
Total non-current assets98 M210 M193 M195 M213 M176 M197 M194 M186 M172 M
Total non-current liabilities59 M94 M63 M70 M286 M297 M304 M350 M488 M410 M
TotalEquityGrossMinority-37 M300 M308 M293 M318 M221 M211 M302 M43 M201 M
TotalEquityGrossMinorityInterest-37 M300 M308 M293 M318 M221 M211 M302 M43 M201 M
TotalLiabilitiesAndTotalEquityGrossMinorityInterest135 M512 M525 M520 M709 M605 M607 M777 M673 M789 M
TotalNonCurrentLiabilitiesNetMinorityInteres59 M94 M63 M70 M286 M297 M304 M350 M488 M410 M
Treasury stock-3 M
Work in progress5 M
Working capital-77 M183 M249 M240 M391 M334 M318 M459 M344 M439 M
debtc40 M22 M357000.04 M4 M5 M
ltinv78 M15 M127 M5 M125 M103 M260 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University